{
  "id": 13251195,
  "title": "Women with PMOS should get subsidised weight loss drugs, advocates say",
  "url": "https://urgent.news/2026/10/09/women-with-pmos-should-get-subsidised-weight-loss-drugs-advocates-say-13251195",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-09T23:00:41.000Z",
  "source": {
    "name": "The Guardian Australia",
    "slug": "the-guardian-australia",
    "url": "https://www.theguardian.com/australia-news/2026/oct/10/women-with-pmos-should-get-subsidised-weight-loss-drugs-advocates-say"
  },
  "original_language": "en",
  "account": null,
  "summary": "Women with Polycystic Ovary Syndrome (PCOS), also referred to as Polyendrocrine Metabolic Ovarian Syndrome, are advocating for access to subsidized weight loss medications. The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is pushing for GLP-1 drugs to be included on the Pharmaceutical Benefits Scheme for individuals with this condition.\n\nCurrently, GLP-1 drugs used to treat PCOS are not specifically approved by the Therapeutic Goods Administration (TGA) for this purpose, resulting in off-label prescriptions for patients. According to The Guardian Australia and The Guardian, advocates believe that making these medications available through the Pharmaceutical Benefits Scheme would provide necessary support for women managing the condition.\n\nThe condition, PCOS or Polyendrocrine Metabolic Ovarian Syndrome, is a chronic hormonal disorder that affects women. POSAA's advocacy aims to improve treatment options for those affected.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Guardian",
        "title": "Women with PMOS should get subsidised weight loss drugs, advocates say",
        "url": "https://urgent.news/2026/10/09/women-with-pmos-should-get-subsidised-weight-loss-drugs-advocates-say",
        "published": "2026-10-09T23:00:41.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}